
|Articles|April 1, 2012
- Applied Clinical Trials-04-01-2012
- Volume 21
- Issue 4
Applied Clinical Trials Digital Edition - April 2012
INFORMATION TECHNOLOGY : Enhancing Risk Assessment and Mitigation REGULATORY : Sunshine Act?s Impact on the Industry Implementation of Objective Internal Monitoring Also in this issue : Impact of Transparency Policies, EMA?s Executive Director Faces Multiple Challenges, The Roles of Healthcare and Research, HIV Vaccine Trials
Advertisement
Articles in this issue
almost 14 years ago
Business and News Update April 2012almost 14 years ago
Transparency, Sunshine Shape Researchalmost 14 years ago
When Worlds Collide: Healthcare and Researchalmost 14 years ago
CRO Founded to Address Neglected Diseases in Under Served Countriesalmost 14 years ago
EFGCP Acts to Reduce Ethics Problemsalmost 14 years ago
Sunshine Act's Impactalmost 14 years ago
Keeping a Cool Head Amidst Turmoilalmost 14 years ago
Startup Offers New Take on Recruitmentalmost 14 years ago
Risk Assessment and MitigationNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
2
Women as the Missing Voice in Parkinson’s Disease
3
Rethinking Site Activation to Cut Startup Timelines
4
ACT Brief: AI Extends Trial Registries, Contract Bottlenecks Delay Activation, and Data Integration Pushes Integrated Care
5



